[
  {
    "ts": "2025-11-13T09:40:00+00:00",
    "headline": "2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors",
    "summary": "Healthcare stocks have plenty to offer new investors.",
    "url": "https://www.fool.com/investing/2025/11/13/quality-healthcare-stock-begin-investor-lly-hims/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a402df7b-bac8-37a9-b9fa-36e1f8d41669",
      "content": {
        "id": "a402df7b-bac8-37a9-b9fa-36e1f8d41669",
        "contentType": "STORY",
        "title": "2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors",
        "description": "",
        "summary": "Healthcare stocks have plenty to offer new investors.",
        "pubDate": "2025-11-13T09:40:00Z",
        "displayTime": "2025-11-13T09:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "investor looking at laptop in kitchen",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bZKQ2Ghc1HxR4DsmVqlAEQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vms4uS1AtguTlqeMXnZuWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/quality-healthcare-stock-begin-investor-lly-hims/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-quality-healthcare-stocks-could-094000924.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HIMS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T09:25:00+00:00",
    "headline": "1 Incredible Reason to Buy LLY's Stock in November",
    "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
    "url": "https://www.fool.com/investing/2025/11/13/incredible-reason-buy-lilly-stock-november-lly/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "07eea724-4a25-3d2c-b187-fd8159a3be97",
      "content": {
        "id": "07eea724-4a25-3d2c-b187-fd8159a3be97",
        "contentType": "STORY",
        "title": "1 Incredible Reason to Buy LLY's Stock in November",
        "description": "",
        "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
        "pubDate": "2025-11-13T09:25:00Z",
        "displayTime": "2025-11-13T09:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A basket of prescription drugs, with a lengthy cash-register receipt.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ieOEbvgFsUoqv8CzTFRZiA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3LLUaSFfXLdxbFHAM1z8bg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/incredible-reason-buy-lilly-stock-november-lly/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-incredible-reason-buy-llys-092500558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T10:15:00+00:00",
    "headline": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
    "summary": "These top growth stocks have plenty of room left to run.",
    "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
      "content": {
        "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
        "contentType": "STORY",
        "title": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
        "description": "",
        "summary": "These top growth stocks have plenty of room left to run.",
        "pubDate": "2025-11-13T10:15:00Z",
        "displayTime": "2025-11-13T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab",
          "originalWidth": 1400,
          "originalHeight": 978,
          "caption": "professional thoughtful investor ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0zgFcCdo1wBatd4Z_KJgfg--~B/aD05Nzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 1400,
              "height": 978,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FJAvhMuIQ0.26A5wB2Z4XQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-growth-healthcare-stocks-every-101500662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:26:37+00:00",
    "headline": "LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan",
    "summary": "Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs",
    "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "ab2befa7-1b0c-3e69-89d4-e85400d19b75",
      "content": {
        "id": "ab2befa7-1b0c-3e69-89d4-e85400d19b75",
        "contentType": "STORY",
        "title": "LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan",
        "description": "",
        "summary": "Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs",
        "pubDate": "2025-11-13T12:26:37Z",
        "displayTime": "2025-11-13T12:26:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:00:00+00:00",
    "headline": "Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management",
    "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (\"Mangoceuticals\" or the \"Company\"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to announce that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbound® (t",
    "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6952f4e0-d171-3970-9b60-067492c99b05",
      "content": {
        "id": "6952f4e0-d171-3970-9b60-067492c99b05",
        "contentType": "STORY",
        "title": "Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management",
        "description": "",
        "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (\"Mangoceuticals\" or the \"Company\"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to announce that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbound® (t",
        "pubDate": "2025-11-13T12:00:00Z",
        "displayTime": "2025-11-13T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca",
          "originalWidth": 8000,
          "originalHeight": 4500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XnuNJ9Qe6ko.i5UiATBWRA--~B/aD00NTAwO3c9ODAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 8000,
              "height": 4500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yet6sa3uxTjLL1d634T49w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MGRX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T13:00:00+00:00",
    "headline": "MeiraGTx Reports Third Quarter 2025 Financial and Operational Results",
    "summary": "Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released material under the Company’s Specials license for a second rare pediatric ophthalmology condition caused by mutations in BBS10, with the prescribing physician treating the first patient during the quarte",
    "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "812c53ea-de5a-309c-897d-e44cb77c046d",
      "content": {
        "id": "812c53ea-de5a-309c-897d-e44cb77c046d",
        "contentType": "STORY",
        "title": "MeiraGTx Reports Third Quarter 2025 Financial and Operational Results",
        "description": "",
        "summary": "Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released material under the Company’s Specials license for a second rare pediatric ophthalmology condition caused by mutations in BBS10, with the prescribing physician treating the first patient during the quarte",
        "pubDate": "2025-11-13T13:00:00Z",
        "displayTime": "2025-11-13T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584",
          "originalWidth": 404,
          "originalHeight": 80,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LLrv0pWs64Owa1k4_MUk_Q--~B/aD04MDt3PTQwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584.cf.webp",
              "width": 404,
              "height": 80,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zCWlLjc7lkVTrKj0pb0egA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MGTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T13:07:00+00:00",
    "headline": "Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month",
    "summary": "As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.",
    "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1efc532f-b50e-31ff-8c47-35005ea467a2",
      "content": {
        "id": "1efc532f-b50e-31ff-8c47-35005ea467a2",
        "contentType": "STORY",
        "title": "Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month",
        "description": "",
        "summary": "As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.",
        "pubDate": "2025-11-13T13:07:00Z",
        "displayTime": "2025-11-13T13:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718",
          "originalWidth": 620,
          "originalHeight": 438,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C4sxFiG08TiZ3eQTIwZmAg--~B/aD00Mzg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718.cf.webp",
              "width": 620,
              "height": 438,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZdidrD47NJkM00idB6nMCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "IBRN"
            },
            {
              "symbol": "FTXH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]